Gapping down
In reaction to earnings/guidance:
- NTNX -37.4%, SNOW -12.4%, ZUO -9.4%, VSAT -6.3%, NVDA -4.7% (also increases and extends share repurchase program to $15 bln), MDT -3.4%, DXC -2.9%, ZTO -2.4%, BOX -1.8%, LU -1.5% (also also CFO to retire)
Other news:
- AVDL -15.7% (received a proposed final label and medication guide for FT218 from the FDA)
- BBIG -10.6% (delays distribution date for Cryptyde spin-off)
- DDOG -4.8% (in sympathy with SNOW earnings)
- MIRM -4.7% (stock offering)
- HQI -3.8% (files for $100 mln mixed securities shelf offering)
- ADC -3.7% (prices offering of 5.0 mln shares of common stock at $68.65 per share)
- NRIX -2.1% (announces positive dose finding data in chronic lymphocytic leukemia and advances NX-2127 to next phase of clinical development)
- AMD -1.2% (in sympathy with NVDA earnings)
- AVGO -1% (acquires VMW; also reported earnings)
Analyst comments:
- ASGN -4.2% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- PUMP -2.3% (downgraded to Underweight from Overweight at JP Morgan)
- TBI -1.7% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- CAH -1.6% (downgraded to Equal Weight from Overweight at Barclays )
- CMCO -1.3% (downgraded to Neutral from Overweight at JP Morgan)
- CNC -1.2% (downgraded to Neutral from Buy at BofA Securities)